<DOC>
	<DOCNO>NCT00090714</DOCNO>
	<brief_summary>The purpose study determine optimum effective dose recombinant plasmid DNA [ pVGI.1 ( VEGF2 ) ] gene therapy administer use experimental cardiac direct injection catheter ( Stiletto™ ) system need benefit patient severe Angina Pectoris .</brief_summary>
	<brief_title>To Find Best Dose pVGI.1 ( VEGF2 ) Benefit Angina Patients When Given With Experimental Injection Catheter</brief_title>
	<detailed_description />
	<mesh_term>Angina Pectoris</mesh_term>
	<criteria>Are willing able give inform consent Have CCS class III IV angina refractory optimized medical therapy Experience sign symptom angina exercise tolerance test ( ETT ) Have identify area ( ) reversible ischemic myocardium Have procedurally acceptable target treatment zone Have exerciselimited noncardiac chest discomfort Unwilling unable undergo exercise test Able exercise great 6 minute treadmill Are candidate conventional revascularization procedure Are enrol within 30 day , another experimental study Have recent angiogram 6 Months prior screen Previously receive investigational angiogenic agent Have another disease severe enough limit exercise test place patient risk Have uncontrolled : atrial fibrillation , atrial flutter , and/or significant arrhythmia Have evidence leave ventricular aneurysm ventricular thrombus Are unwilling unable undergo cardiac catheterization nuclear testing procedure Have Qwave MI , within 60 day Have severe aortic valve stenosis mechanical aortic mitral valve Have unstable angina acute nonQwave myocardial infarction within 14 day Have document stroke transient ischemic attack within 60 day Are pacemaker dependent Have recent history active diabetic retinopathy agerelated wet macular degeneration Have history cancer within last 5 yr . current evidence malignant neoplasm Have history alcohol drug abuse within 90 day Are pregnant lactate Have reproductive potential unwilling use condom contraception 1 year treatment – male female Are unable return clinic schedule followup appointment Are take medication may produce undue risk Have area LV wall le 6mm thick</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2006</verification_date>
	<keyword>DNA</keyword>
	<keyword>Circular</keyword>
	<keyword>Gene Therapy</keyword>
</DOC>